Table of Contents Understanding GLP-1 Therapy in Type 1 Diabetes Potential Benefits and Clinical Outcomes Risks, Safety Concerns, and Limitations Patient Selection and Practical Considerations Understanding GLP-1 Therapy in Type 1 Diabetes GLP-1 receptor agonists are well established in type 2 diabetes, yet their role in type 1 diabetes remains off-label
Tc dng h tr: Tng cng n hi cho da, gim thiu np nhn, gip da cng mn v ti tn
FDA-approved under brand names such as Saxenda for chronic weight management and Victoza for type 2 diabetes, liraglutide works by reducing appetite, increasing feelings of fullness, and slowing gastric emptying to help support sustainable weight loss
Written informed consent for participation was not required from the participants or the participants legal guardians/next of kin in accordance with the national legislation and institutional requirements
Focus on protein targets, listen to your body, and use these snack ideas as tools to support your health goals during GLP-1 treatment